| [1] |
Lee DW, Cho CM. Predicting severity of acute pancreatitis[J]. Medicina (Kaunas), 2022, 58(6): 787.
|
| [2] |
Voronina S, Chvanov M, De Faveri F, et al. Autophagy, acute pancreatitis and the metamorphoses of a trypsinogen-activating organelle[J]. Cells, 2022, 11(16): 2514.
|
| [3] |
陈亮, 杨硕菲, 薛冠华. NLRP3炎症小体与血栓形成的关系研究进展[J]. 中华普通外科杂志, 2023, 38(9) : 710-713.
|
| [4] |
Liu T, Wang Q, Du Z, et al. The trigger for pancreatic disease: NLRP3 inflammasome[J]. Cell Death Discov, 2023, 9(1): 246.
|
| [5] |
Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation[J]. Int J Mol Sci, 2019, 20(13): 3328.
|
| [6] |
Qiang R, Li Y, Dai X, et al. NLRP3 inflammasome in digestive diseases: from mechanism to therapy[J]. Front Immunol, 2022, 13: 978190.
|
| [7] |
Zhao N, Li CC, Di B, et al. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: mechanisms, role in diseases and related inhibitors[J]. J Autoimmun, 2020, 113: 102515.
|
| [8] |
Que X, Zheng S, Song Q, et al. Fantastic voyage: the journey of NLRP3 inflammasome activation[J]. Genes Dis, 2024, 11(2): 819-829.
|
| [9] |
Chen Z, Zhang M, Zhao Y, et al. Hydrogen sulfide contributes to uterine quiescence through inhibition of NLRP3 inflammasome activation by suppressing the TLR4/NF-κB signalling pathway[J]. J Inflamm Res, 2021, 14: 2753-2768.
|
| [10] |
Shen Y, Yang H, Wu D, et al. NLRP3 inflammasome inhibitor MCC950 can reduce the damage of pancreatic and intestinal barrier function in mice with acute pancreatitis[J]. Acta Cir Bras, 2022, 37(7): e370706.
|
| [11] |
Chu LH, Indramohan M, Ratsimandresy RA, et al. The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages[J]. Nat Commun, 2018, 9(1): 996.
|
| [12] |
Hussain T, Murtaza G, Metwally E, et al. The role of oxidative stress and antioxidant balance in pregnancy[J]. Mediators Inflamm, 2021, 2021: 9962860.
|
| [13] |
Gong C, Yang H, Wang S, et al. hTERT promotes CRC proliferation and migration by recruiting YBX1 to increase NRF2 expression[J]. Front Cell Dev Biol, 2021, 9: 658101.
|
| [14] |
Kong L, Zhang H, Lu C, et al. AICAR, an AMP-activated protein kinase activator, ameliorates acute pancreatitis-associated liver injury partially through Nrf2-mediated antioxidant effects and inhibition of NLRP3 inflammasome activation[J]. Front Pharmacol, 2021, 12: 724514.
|
| [15] |
Xiang H, Guo F, Tao X, et al. Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation[J]. Theranostics, 2021, 11(9): 4467-4482.
|
| [16] |
Kim ER, Kim SR, Cho W, et al. Short term isocaloric ketogenic diet modulates NLRP3 inflammasome via B-hydroxybutyrate and fibroblast growth factor 21[J]. Front Immunol, 2022, 13: 843520.
|
| [17] |
Li XY, He C, Zhu Y, et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis[J]. World J Gastroenterol, 2020, 26(18): 2187-2193.
|
| [18] |
Jia L, Chen H, Yang J, et al. Combinatory antibiotic treatment protects against experimental acute pancreatitis by suppressing gut bacterial translocation to pancreas and inhibiting NLRP3 inflammasome pathway[J]. Innate Immun, 2020, 26(1): 48-61.
|
| [19] |
Ferrero-Andrés A, Panisello-Roselló A, Roselló-Catafau J, et al. NLRP3 inflammasome-mediated inflammation in acute pancreatitis[J]. Int J Mol Sci, 2020, 21(15): 5386.
|
| [20] |
Li H, Xie J, Guo X, et al. Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses[J]. Gut Microbes, 2022, 14(1): 2127456.
|
| [21] |
Li X, He C, Li N, et al. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice[J]. Gut Microbes, 2020, 11(6): 1774-1789.
|
| [22] |
Quiroga R, Nistal E, Estébanez B, et al. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children[J]. Exp Mol Med, 2020, 52(7): 1048-1061.
|
| [23] |
Coll RC, Schroder K, Pelegrín P. NLRP3 and pyroptosis blockers for treating inflammatory diseases[J]. Trends Pharmacol Sci, 2022, 43(8): 653-668.
|
| [24] |
Wu X, Yao J, Hu Q, et al. Emodin ameliorates acute pancreatitis-associated lung injury through inhibiting the alveolar macrophages pyroptosis[J]. Front Pharmacol, 2022, 13: 873053.
|
| [25] |
Wu XB, Sun HY, Luo ZL, et al. Plasma-derived exosomes contribute to pancreatitis-associated lung injury by triggering NLRP3-dependent pyroptosis in alveolar macrophages[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(5): 165685.
|
| [26] |
Sun B, Chen Z, Chi Q, et al. Endogenous tRNA-derived small RNA (tRF3-Thr-AGT) inhibits ZBP1/NLRP3 pathway-mediated cell pyroptosis to attenuate acute pancreatitis (AP)[J]. J Cell Mol Med, 2021, 25(22): 10441-10453.
|
| [27] |
Zhang Q, Tao X, Xia S, et al. Emodin attenuated severe acute pancreatitis via the P2X ligand-gated ion channel 7/NOD-like receptor protein 3 signaling pathway[J]. Oncol Rep, 2019, 41(1): 270-278.
|
| [28] |
Jiang N, Li Z, Luo Y, et al. Emodin ameliorates acute pancreatitis-induced lung injury by suppressing NLRP3 inflammasome-mediated neutrophil recruitment[J]. Exp Ther Med, 2021, 22(2): 857.
|
| [29] |
Xu Q, Wang M, Guo H, et al. Emodin alleviates severe acute pancreatitis-associated acute lung injury by inhibiting the cold-inducible rna-binding protein (CIRP)-mediated activation of the NLRP3/IL-1β/CXCL1 signaling[J]. Front Pharmacol, 2021, 12: 655372.
|